RGNX(REGENXBIO Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-27 | Ciongoli Gregory Austin | 董事 | 公开市场买入 | 53,407 | $9.36 |
| 2026-08-26 | Ciongoli Gregory Austin | 董事 | 公开市场买入 | 49,196 | $9.14 |
| 2026-07-02 | PAKOLA STEVE | Chief Medical Officer | 公开市场卖出 | 2,161 | $13.64 |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | 公开市场卖出 | 36,725 | $12.86 |
| 2026-06-29 | PAKOLA STEVE | Chief Medical Officer | 公开市场卖出 | 19,608 | $11.04 |
| 2026-05-11 | PAKOLA STEVE | Chief Medical Officer | 公开市场卖出 | 15,309 | $11.02 |
| 2026-03-10 | PAKOLA STEVE | Chief Medical Officer | 公开市场卖出 | 5,124 | $10.35 |
| 2025-10-09 | Simpson Curran | Chief Executive Officer | 公开市场卖出 | 20,811 | $12.62 |
| 2025-09-29 | Simpson Curran | Chief Executive Officer | 公开市场卖出 | 7,624 | $10.03 |
| 2025-09-10 | Simpson Curran | Chief Executive Officer | 公开市场卖出 | 7,734 | $10.02 |
| 2025-05-12 | Mills Kenneth T. | 董事 | 公开市场卖出 | 20,602 | $7.91 |